Mubadala-backed Manipal Hospitals heads for USD 1.2 bn listing
The hospital player’s market debut will serve as a test for investor appetite for specialty healthcare amid persistent geopolitical volatility
Available in your choice of English or Arabic
The hospital player’s market debut will serve as a test for investor appetite for specialty healthcare amid persistent geopolitical volatility
Plus: India pulls on all levers to defend the INR
Topical Indian drug maker Encube Ethicals emerges as a beneficiary as US moves away from China’s pharma supply chain
SWF investment in Indian startups fell to USD 225 mn in 2025
The allotment follows RCPL’s demerger from RRVL and aligns its investor base with Reliance’s wider retail ecosystem
Flush with liquidity and diversifying away from hydrocarbons, Gulf sovereign funds are tilting India allocations toward financials, infrastructure and domestic…
Queue